BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Helius Medical Technologies Completes Reverse Split of its Class A Common Stock

  Helius Class A common stock will begin trading on a post-split basis at market open on January 23, 2018.

  January 23, 2018

   · 

  6 min read
• Univercells Granted $2.9M to Develop Antibody Production Platform

  This funding will enable the company to launch a program aimed at developing its innovative protein platform, paving the way for the cost-effective production of biosimilars.

  January 23, 2018

   · 

  3 min read
• Consortium Including Trakcel Awarded GBP 1.4 Million From Innovate UK for Commercialisation of Rexgenero Cell Therapy

  The project will focus on and design a cost effective commercial manufacturing strategy for Rexgenero’s novel autologous cell therapy REX-001.

  January 23, 2018

   · 

  2 min read